(Q53160550)

12 May 2018

title

TNF receptor-associated factor 6 in advanced non-small cell lung cancer: clinical and prognostic implications. (English)

1 reference

12 May 2018

0 references

Hui Liu

1

1 reference

12 May 2018

Tiantuo Zhang

2

1 reference

12 May 2018

Jin Ye

3

1 reference

12 May 2018

Hongtao Li

4

1 reference

12 May 2018

Jing Huang

5

1 reference

12 May 2018

Xiaodong Li

6

1 reference

12 May 2018

Benquan Wu

7

1 reference

12 May 2018

Xubing Huang

8

1 reference

12 May 2018

Jinghui Hou

9

1 reference

12 May 2018

publication date

27 June 2012

1 reference

12 May 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

12 May 2018

volume

138

1 reference

12 May 2018

issue

11

1 reference

12 May 2018

page(s)

1853-1863

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1007/s00432-012-1255-6

exact match

0 references

cites work

Tumor necrosis factor receptor-associated factors (TRAFs)

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

TRAF6 inhibits Th17 differentiation and TGF-beta-mediated suppression of IL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

CD40 ligand-induced carcinoma cell death: a balance between activation of TNFR-associated factor (TRAF) 3-dependent death signals and suppression of TRAF6-dependent survival signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

Late phase activation of nuclear transcription factor kappaB by doxorubicin is mediated by interleukin-8 and induction of apoptosis via FasL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

Histological typing of lung and pleural tumours: third edition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

TRAF6 regulates cell fate decisions by inducing caspase 8-dependent apoptosis and the activation of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

CD40-mediated cell death requires TRAF6 recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

TRAF6 Is a Critical Factor for Dendritic Cell Maturation and Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

The role of TRAF6 in signal transduction and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

Modulation of life and death by the tumor necrosis factor receptor-associated factors (TRAFs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

Characterization of apoptosis and proliferation in esophageal carcinoma EC109 cells following siRNA-induced down-regulation of TRAF6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

TRAF6 directs commitment to regulatory T cells in thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

Physiological and molecular effects of Apo2L/TRAIL and cisplatin in ovarian carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

Targeting TRAfs for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1255-6

Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer

21 January 2018

1 reference

12 December 2020

MyD88 and TNF receptor-associated factor 6 are critical signal transducers in Helicobacter pylori-infected human epithelial cells

1 reference

12 December 2020

Renal cell carcinoma: resistance to therapy, role of apoptosis, and the prognostic and therapeutic target potential of TRAF proteins

1 reference

12 December 2020

CD95 and TRAF2 promote invasiveness of pancreatic cancer cells.

1 reference

12 December 2020

The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma

1 reference

12 December 2020

TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis

1 reference

12 December 2020

TNF receptor-associated factor 6 deficiency during hemopoiesis induces Th2-polarized inflammatory disease

1 reference

12 December 2020

Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy.

1 reference

12 December 2020

10.1007/S00432-012-1255-6

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018